ElGendy Mohamed H, Fetoh Sarah A, Salem Shaimaa E, Daihom Baher A, Fahmy Ebtesam M, ElMeligie Mohamed M
Basic Sciences Department, Faculty of Physical Therapy, Cairo University, Giza, Egypt.
Faculty of Physical Therapy, October 6 University, Giza, Egypt.
J Hand Ther. 2024 Oct-Dec;37(4):653-661. doi: 10.1016/j.jht.2024.02.006. Epub 2024 Mar 6.
Cubital tunnel syndrome (CBTS) impairs hand function, with limited conservative options often leading to surgery. Chitosan neuroregenerative effects delivered via phonophoresis provide a rationale for testing this emerging treatment approach.
The primary goal of this research was to assess the impact of chitosan phonophoresis on the conductivity of the ulnar nerve, as well as its effects on pain levels and functional outcomes in individuals diagnosed with mild to moderate CBTS.
Double-blind randomized controlled trial.
This was a prospective, double-blinded, randomized controlled study. The participants consisted of 54 individuals aged between 20-35 years who were randomly assigned using block randomization. The control group (n = 27) received standard hand therapy alone, while the experimental group (n = 27) received both standard hand therapy and chitosan phonophoresis. Both groups underwent three treatment sessions per week, each lasting for 60-72 minutes, over a period of five weeks. Pre- and post-intervention evaluations included assessments of ulnar nerve conduction velocity (NCV), pain assessment using the numerical pain rating scale (NPRS), as well as hand function evaluated using the Quick Disabilities of Arm Shoulder Hand (QuickDASH) questionnaire.
After the intervention, the experimental group significantly improved in all outcome measures compared to the control group. Accordingly, ulnar NCV (MD = 2.233 m/sec; CI = 1.63:2.83; p < 0.001; η = 0.516), NPRS (MD = -1.11; CI = -1.71: -0.50; p < 0.001; η = 0.208) and QuickDASH (MD = -2.72; CI = -4.54:0.87; p < 0.007; η = 0.133).
The study findings suggest that chitosan phonophoresis may have the potential as a supplementary treatment to hand therapy for individuals with mild to moderate CBTS. This approach demonstrated significant improvements in nerve conduction, pain reduction, and enhancement of hand function.
肘管综合征(CBTS)会损害手部功能,保守治疗选择有限,常需进行手术。通过超声导入传递的壳聚糖神经再生作用为测试这种新兴治疗方法提供了理论依据。
本研究的主要目标是评估壳聚糖超声导入对尺神经传导性的影响,以及对诊断为轻度至中度CBTS患者的疼痛水平和功能结果的影响。
双盲随机对照试验。
这是一项前瞻性、双盲、随机对照研究。参与者为54名年龄在20至35岁之间的个体,采用区组随机化进行随机分配。对照组(n = 27)仅接受标准手部治疗,而实验组(n = 27)接受标准手部治疗和壳聚糖超声导入。两组每周进行三次治疗,每次持续60 - 72分钟,为期五周。干预前后的评估包括尺神经传导速度(NCV)评估、使用数字疼痛评分量表(NPRS)进行疼痛评估,以及使用手臂、肩部和手部快速残疾问卷(QuickDASH)评估手部功能。
干预后,实验组在所有结果指标上均比对照组有显著改善。具体而言,尺神经NCV(MD = 2.233米/秒;CI = 1.63:2.83;p < 0.001;η = 0.516)、NPRS(MD = -1.11;CI = -1.71: -0.50;p < 0.001;η = 0.208)和QuickDASH(MD = -2.72;CI = -4.54:0.87;p < 0.007;η = 0.133)。
研究结果表明,壳聚糖超声导入可能有潜力作为轻度至中度CBTS患者手部治疗的辅助治疗方法。这种方法在神经传导、疼痛减轻和手部功能增强方面显示出显著改善。